Thyrocare Technologies Ltd. News and Updates

Name: Latest research reports of Thyrocare Technologies Ltd. authored by Aditya Birla Money Limited and published by - Trendlyne research reports.
Item: Thyrocare Technologies Ltd.
Rating: 3
Author: Aditya Birla Money Limited

Keep track of all breaking news on Thyrocare Technologies Ltd. from all sources in a single place.

Load latest

Thyrocare Technologies Ltd.

27 Apr 2016

953.15

-1.40%

Thyrocare Technologies IPO: Should you subscribe?

Business Standard

Here's a quick compilation of what country's top research and brokerage houses suggest

Thyrocare Technologies Ltd. has gained 48.07% in the last 1 Year

Thyrocare Technologies Ltd.

27 Apr 2016

953.15

-1.40%

IPO Note - Thyrocare Technologies ltd

IPO Note: Thyrocare Technologies Ltd.

Aditya Birla Money Limited

Strong operating performance and asset light model leading to high returns: The franchise model of the company has helped it to minimize its capital expenditure leading to higher returns on equity as well as return on capital employed. TTL's sales...

Thyrocare Technologies Ltd. has gained 34.51% in the last 1 Month

Thyrocare Technologies Ltd.

27 Apr 2016

953.15

-1.40%

Thyrocare IPO note 27Apr2016

Thyrocare Technologies Ltd.

Phillip Capital

chains. It has a leadership position in (the fastest growing and highest valueadded) diagnosticserviceofferingsinwellnessandpreventivecarethismakesitanindustryleader inprofitability.Weexpectittodeliverrevenue/PATCAGRof25%/29%overFY1518.Atthe...

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

27 Apr 2016

953.15

-1.40%

Thyrocare Technologies IPO Note

Thyrocare Technologies Ltd.

BOB Capital Markets Ltd.

The company is a provider of diagnostic and related healthcare tests and services in India and is specialised in preventive and wellness segment of the diagnostics industry which has broader scope to grow with improving life style...

Thyrocare Technologies Ltd. is trading above all available SMAs

Thyrocare Technologies Ltd.

26 Apr 2016

953.15

-1.40%

Thyrocare Technologies Limited

Thyrocare Technologies Ltd.

Angel Broking

Thyrocare Technologies is one of the leading diagnostic chains in India with market share of ~3% amongst organised players. The core business of the company is diagnostic testing (~97.1% of sales as on 9MFY2016) while the company through its wholly owned subsidiary also operates imaging centres. A differentiated model enables higher margi..

Thyrocare Technologies Ltd. has gained 32.72% in the last 3 Months

Thyrocare Technologies Ltd.

25 Apr 2016

953.15

-1.40%

Thyrocare Technologies Ltd - IPO

Thyrocare Technologies Ltd.

ICICI Securities Limited

Thyrocare Technologies (Thyrocare) is one of the leading pan-India diagnostic chains. The company currently offers 198 tests and 59 profiles of tests to detect a number of disorders. Thyrocare also offers patients and...

Thyrocare Technologies Ltd. has gained 48.07% in the last 1 Year

Thyrocare Technologies Ltd.

22 Apr 2016

953.15

-1.40%

Thyrocare Technologies Ltd

IPO Subscribe: Thyrocare Technologies Ltd.

AUM Capital

Thyrocare Technologies Limited (TTL) is one of the leading fully automated diagnostic chains and conducts an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases. Under its Aarogyam' brand it provides 16 profiles of tests which offer patients a suite of wellness and preventive health care tests. It operates with a Centralized Processing Laboratory (CPL) in Mumbai for esoteric tests and Regional Processing Laboratory (RPL) in major metros of India and other parts of Asia. The...

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

22 Apr 2016

953.15

-1.40%

Thyrocare Technologies Ltd.

IPO Subscribe: Thyrocare Technologies Ltd.

Ashika Research

The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of 10,744,708 Equity Shares by the Selling Shareholders (up to 10,207,472 Eq Sh by Agalia; up to 180,000 Eq Sh by A. Sundararaju HUF; up to 180,000 Eq Sh by A. Velumani HUF and up to 177,236 Eq Sh by Anand Velumani). The Company will not receive any proceeds of the...

Thyrocare Technologies Ltd. has gained 34.51% in the last 1 Month

Is Thyrocare Technologies Ltd. worth buying?

164 Votes:

Buy 76.83%

Sell 12.2%

Hold 10.98%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf

66.81% Gain from 52W Low

Thyrocare Technologies Ltd. News and Updates

Keep track of all breaking news on Thyrocare Technologies Ltd. from all sources in a single place.